Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
PRAMIPEXOL ARENA 0,7 mg
Dopaminergic agonist indicated in the treatment of Parkinson's disease
Tablets
0,7 mg
PREDNISON ARENA 5 mg
Corticosteroid with anti-inflammatory and immunosuppressive effect, indicated in inflammatory and autoimmune conditions
Tablets
5 mg
PROPAFENONA ARENA 150 mg
Antiarrhythmic drug indicated in the treatment of cardiac rhythm disorders
Tablets
150 mg
PROPRANOLOL ARENA 10 mg
Non-selective beta-blocker indicated in arterial hypertension, essential tremor and cardiac rhythm disorders
Tablets
10 mg
PROPRANOLOL ARENA 40 mg
Non-selective beta-blocker indicated in arterial hypertension, essential tremor and cardiac rhythm disorders
Tablets
40 mg
RALOXIFEN ARENA 60 mg
Selective oestrogen receptor modulator, indicated in the prevention and treatment of postmenopausal osteoporosis
Film-coated tablets
60 mg
RIFAMPICINA ARENA 150 mg
Essential antituberculosis antibiotic, first-line in the treatment of tuberculosis
Capsules
150 mg
RISEDRONAT ARENA 30 mg
Bisphosphonate indicated in the treatment and prevention of osteoporosis
Film-coated tablets
30 mg
RISEDRONAT ARENA 35 mg
Bisphosphonate indicated in the treatment and prevention of osteoporosis
Film-coated tablets
35 mg